SH3GL2 and Alzheimer disease: LINC00094 was dramatically increased in the Aβ-incubated BBB model. LINC00094 reduction inhibited the expression of SH3GL2 through up-regulation of miR-224-5p/miR-497-5p and finally resulted in alleviated permeability of BBB in the AD microenvironment.